[go: up one dir, main page]

MX2019000114A - Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano. - Google Patents

Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano.

Info

Publication number
MX2019000114A
MX2019000114A MX2019000114A MX2019000114A MX2019000114A MX 2019000114 A MX2019000114 A MX 2019000114A MX 2019000114 A MX2019000114 A MX 2019000114A MX 2019000114 A MX2019000114 A MX 2019000114A MX 2019000114 A MX2019000114 A MX 2019000114A
Authority
MX
Mexico
Prior art keywords
scavengers
healthspan
ketoaldehydes
extend cell
cell lifespan
Prior art date
Application number
MX2019000114A
Other languages
English (en)
Inventor
Jackson Roberts Ii L
T Nguyen Thuy
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of MX2019000114A publication Critical patent/MX2019000114A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Métodos y compuestos para usarse en la promoción de la supervivencia de al menos una célula eucariota, en donde los compuestos son efectivos como neutralizadores de gamma-cetoaldehído.
MX2019000114A 2016-07-06 2017-07-06 Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano. MX2019000114A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662359183P 2016-07-06 2016-07-06
PCT/US2017/040982 WO2018009720A1 (en) 2016-07-06 2017-07-06 Use of scavengers of reactive gamma-ketoaldehydes to extend cell lifespan and healthspan

Publications (1)

Publication Number Publication Date
MX2019000114A true MX2019000114A (es) 2019-04-01

Family

ID=60912291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000114A MX2019000114A (es) 2016-07-06 2017-07-06 Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano.

Country Status (9)

Country Link
US (1) US11633370B2 (es)
EP (1) EP3481798A4 (es)
JP (2) JP2019524703A (es)
CN (1) CN109689619A (es)
AU (1) AU2017293846B2 (es)
BR (1) BR112019000216B1 (es)
CA (1) CA3030036A1 (es)
MX (1) MX2019000114A (es)
WO (1) WO2018009720A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018201074A1 (en) * 2017-04-27 2018-11-01 Vanderbilt University Methods for treating atherosclerosis with gamma-ketoaldehyde scavengers
BR112021014696A2 (pt) * 2019-01-25 2021-12-28 Univ Vanderbilt Sequestrantes isocetais/de isolevuglandina que têm mitocôndria como alvo
AU2021360501A1 (en) * 2020-10-13 2023-06-22 Vanderbilt University Method of preventing kidney injury disruption of intestinal lymphatics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7705054B1 (en) * 2004-10-20 2010-04-27 Vanderbilt University Method of preventing and/or treating oxidant injury in neurodegenerative and oxidative diseases
US8822542B2 (en) * 2004-10-20 2014-09-02 Vanderbilt University Isoketal scavengers and mitigation of disorders involving oxidative injury
CN103796648B (zh) 2011-07-12 2019-10-25 范德比尔特大学 用γ-醛酮清除剂治疗炎症和高血压的方法

Also Published As

Publication number Publication date
EP3481798A1 (en) 2019-05-15
WO2018009720A1 (en) 2018-01-11
JP2023113705A (ja) 2023-08-16
JP2019524703A (ja) 2019-09-05
BR112019000216A2 (pt) 2019-04-16
AU2017293846A1 (en) 2019-01-31
BR112019000216B1 (pt) 2023-04-18
AU2017293846B2 (en) 2022-03-17
US11633370B2 (en) 2023-04-25
US20190240170A1 (en) 2019-08-08
CA3030036A1 (en) 2018-01-11
CN109689619A (zh) 2019-04-26
EP3481798A4 (en) 2020-03-11

Similar Documents

Publication Publication Date Title
HUS2500012I1 (hu) B-sejtes rosszindulatú daganatok és más rákos megbetegedések kezelésére alkalmas autológ T-sejtek elõállításának módszerei és azok készítményei
IL255447B1 (en) Optimal solid surfaces, tools to use them and their uses to encourage cell and tissue growth
MX2021004479A (es) Agentes biologicos y su uso en plantas.
GB2531952A (en) SC-ß cells and compositions and methods for generating the same
MY193806A (en) Affinity-oligonucleotide conjugates and uses thereof
EP3697820A4 (en) PROCEDURES AND COMPOSITIONS RELATED TO MANIPULATED REGULATORY T-CELLS
SG10201808922XA (en) Systems and methods for concurrent spectrum usage within actively used spectrum
MY199019A (en) Pd-1 antibodies
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
EP3331582A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRANSPLANTATION CELLS
MY181994A (en) Immuno-modulatory progenitor (imp) cell
MX376916B (es) Composiciones para el tratamiento de espasmos gastrointestinales.
MX2017007645A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX377593B (es) Composiciones para usar en el tratamiento de cáncer renal.
MX2017000142A (es) Celulas estromales mesenquimatosas para tratar el sindrome de respuesta inflamatoria sistemica.
MX2015003711A (es) Metodos y composiciones para extender la vida útil en déposito de productos de plantas.
EP3145516A4 (en) Methods and compositions for treating malignancies with dendritic cells
MX2019013642A (es) Compuestos, composiciones y metodos.
WO2015171852A3 (en) Methods and compositions for non-cytotoxic stem cell transplantation
MX384259B (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
CL2016002532A1 (es) Compuestos derivados de diheterociclo enlazado a cicloalquilo con actividad inhibidora de gls1 uso en el tratamiento de crecimiento celular anormal, tal como cáncer composición farmacéutica que los contiene
MX2019000114A (es) Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano.
IN2014CH00151A (es)
MX369455B (es) Métodos mejorados para tratamiento de grano con ozono.